JashinJoaquinWuMD
Dermatology • Irvine, CAFounder and CEO, Dermatology Research and Education Foundation
Dr. Wu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
20 Cassidy
Irvine, CA 92620Phone+1 818-216-3594
Education & Training
University of California (Irvine)Residency, Dermatology, 2005 - 2008
Baylor College of MedicineInternship, Internal Medicine, 2002 - 2003
Northwestern University The Feinberg School of MedicineClass of 2002
Certifications & Licensure
CA State Medical License 2004 - 2026
TX State Medical License 2003 - 2004- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO) Start of enrollment: 2014 Jun 16
Publications & Presentations
PubMed
- Innovations in Psoriasis.Amylee Martin, Marina Kristy Ibraheim, Rohit Gupta, Jashin J Wu
Dermatologic Clinics. 2025-01-01 - Topical clindamycin for acne vulgaris: analysis of gastrointestinal events.Natalia M Pelet Del Toro, Andrew Strunk, Jashin J Wu, Linda Stein Gold, James Q Del Rosso
The Journal of Dermatological Treatment. 2024-12-01 - Patient-Identified Treatment Goals for Psoriatic Disease: Results From a US Patient Survey.April Armstrong, Noah A Levit, Beth Schneider, Richard Seiden, Linyu Shi
Journal of Psoriasis and Psoriatic Arthritis. 2024-10-14
Journal Articles
- Efficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients with Moderate to Severe Plaque PsoriasisAndrew Blauvelt, Craig L Leonardi, Jashin J Wu, JAMA Dermatology
- Dietary Recommendations for Adults with Psoriasis or Psoriatic Arthritis from the Medical Board of the National Psoriasis FoundationRonald Prussick, Johann E Gudjonsson, Alice Gottlieb, John Koo, Jerry Bagel, Adam R Ford, Joseph A Markenson, Wilson Liao, Joseph F Merola, Jashin J Wu, JAMA
Authored Content
- Efficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients with Moderate to Severe Plaque PsoriasisApril 2020
Press Mentions
Dissatisfaction with Multiple Facets of Care Reported in Psoriasis & Psoriatic ArthritisNovember 17th, 2024- Topical Tapinarof and Roflumilast for Psoriasis: Where Do They Fit In?September 10th, 2024
- How Do Tapinarof and Roflumilast Creams Fit into Psoriasis Treatment?September 5th, 2024
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
